Company intelligence / Profile preview

Voyager Biomedical

College Station, Texas, United Statesvoyagerbiomedical.com ↗

Ownership: Private
Development stage: Other

Overview

Voyager Biomedical has developed "The Ark," a 3D printed porous titanium alloy device designed to simplify and standardize cannulation for hemodialysis patients. The Ark acts as a supportive exoskeleton for the vein, aiming to reduce injury from repeated needle insertions, improve patient comfort, decrease surgical interventions, and standardize practices across dialysis centers. Clinical results are not explicitly detailed in public sources; the company focuses on innovation and improving outcomes for chronic kidney disease patients undergoing dialysis.

Therapeutic areas: Nephrology
Modalities: Device (specifically, implantable vascular access device for hemodialysis)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Voyager Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voyager Biomedical.

Explore the full profile